Mearns BM - Search Results

1

Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders.

Iismaa SE, Mearns BM, Lorand L, Graham RM. Iismaa SE, et al. Among authors: mearns bm. Physiol Rev. 2009 Jul;89(3):991-1023. doi: 10.1152/physrev.00044.2008. Physiol Rev. 2009. PMID: 19584319 Free article. Review.

2

Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes.

Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kesteven SH, Guan Z, Prall OW, Mearns BM, Feneley MP, Steinberg SF, Graham RM. Chaulet H, et al. Among authors: mearns bm. J Mol Cell Cardiol. 2006 Apr;40(4):540-52. doi: 10.1016/j.yjmcc.2006.01.015. Epub 2006 Mar 6. J Mol Cell Cardiol. 2006. PMID: 16516910

3

Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria.

Krasnikov BF, Kim SY, McConoughey SJ, Ryu H, Xu H, Stavrovskaya I, Iismaa SE, Mearns BM, Ratan RR, Blass JP, Gibson GE, Cooper AJ. Krasnikov BF, et al. Among authors: mearns bm. Biochemistry. 2005 May 31;44(21):7830-43. doi: 10.1021/bi0500877. Biochemistry. 2005. PMID: 15909997 Free PMC article.

4

JACC Pivots to History to Inspire Creativity.

Turco JV, Mearns BM, Fuster V. Turco JV, et al. Among authors: mearns bm. J Am Coll Cardiol. 2021 Jun 1;77(21):2747-2748. doi: 10.1016/j.jacc.2021.04.041. J Am Coll Cardiol. 2021. PMID: 34045028 Free article. No abstract available.

5

Anticoagulation therapy: Preliminary results for the dabigatran-reversal agent idarucizumab.

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Aug;12(8):442. doi: 10.1038/nrcardio.2015.93. Epub 2015 Jul 7. Nat Rev Cardiol. 2015. PMID: 26149484 No abstract available.

6

Hypertension: Benefit of pharmacists prescribing antihypertensive medication.

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Aug;12(8):443. doi: 10.1038/nrcardio.2015.104. Epub 2015 Jun 30. Nat Rev Cardiol. 2015. PMID: 26122022 No abstract available.

7

Dyslipidaemia: Promising results for TA-8995 in TULIP.

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Aug;12(8):443. doi: 10.1038/nrcardio.2015.97. Epub 2015 Jun 23. Nat Rev Cardiol. 2015. PMID: 26099844 No abstract available.

8

Acute coronary syndromes: Should routine oxygen therapy be AVOIDed in normoxic patients with STEMI?

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Aug;12(8):444. doi: 10.1038/nrcardio.2015.94. Epub 2015 Jun 9. Nat Rev Cardiol. 2015. PMID: 26054830 No abstract available.

9

Risk factors: Hand grip strength predicts cardiovascular risk.

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Jul;12(7):379. doi: 10.1038/nrcardio.2015.84. Epub 2015 Jun 2. Nat Rev Cardiol. 2015. PMID: 26031700 No abstract available.

10

Atrial fibrillation: Uninterrupted oral anticoagulation in patients undergoing catheter ablation.

Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 Jul;12(7):381. doi: 10.1038/nrcardio.2015.86. Epub 2015 Jun 2. Nat Rev Cardiol. 2015. PMID: 26031699 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page